Lack of Active Onchocerca Volvulus Transmission in the Northern Chiapas Focus of Mexico
Overview
Authors
Affiliations
The northern Chiapas onchocerciasis focus has undergone 11 years of ivermectin mass treatment. No evidence of microfilariae in the cornea and/or anterior chamber of the eye or in skin snips was seen in residents examined in 2006 in two sentinel communities (upper limit of the 95% confidence interval [UL 95% CI] = 0.5% and 0.3%, respectively). In children 10 and under, 0 of 305 were found to harbor antibodies to Ov16, a marker of parasite exposure; 0 of 4,400 Simulium ochraceum s.l. collected in 2005 contained parasite DNA, giving an UL 95% CI for the infective rate of 0.9/2,000, and an UL 95% CI of the seasonal transmission potential of 1.2 L3/person. These data, assumed to be representative of the focus as a whole, suggest that there is no ongoing transmission of Onchocerca volvulus in the northern Chiapas focus. Community-wide treatments with ivermectin were halted in 2008, and a post-treatment surveillance phase was initiated.
Cama V, Mendizabal-Cabrera R, de Leon O, White M, McDonald C, Thiele E Am J Trop Med Hyg. 2024; 110(5):943-950.
PMID: 38507804 PMC: 11066353. DOI: 10.4269/ajtmh.23-0473.
Guillot C, Bouchard C, Aenishaenslin C, Berthiaume P, Milord F, Leighton P Front Public Health. 2022; 10:1003949.
PMID: 36438246 PMC: 9686450. DOI: 10.3389/fpubh.2022.1003949.
Fernandez-Santos N, Prado-Velasco F, Damian-Gonzalez D, Unnasch T, Rodriguez-Perez M Res Rep Trop Med. 2021; 12:235-245.
PMID: 34737667 PMC: 8558426. DOI: 10.2147/RRTM.S317993.
Coffeng L, Stolk W, Golden A, de Los Santos T, Domingo G, de Vlas S Am J Epidemiol. 2019; 188(9):1723-1732.
PMID: 31062838 PMC: 6735885. DOI: 10.1093/aje/kwz109.
Richards F, Katabarwa M, Bekele F, Tadesse Z, Mohammed A, Sauerbrey M Am J Trop Med Hyg. 2018; 99(3):749-752.
PMID: 30014821 PMC: 6169192. DOI: 10.4269/ajtmh.18-0341.